Victrex (LON:VCT - Get Free Report) had its price target raised by stock analysts at Citigroup from GBX 700 to GBX 1,000 in a report issued on Friday, London Stock Exchange reports. The firm currently has a "neutral" rating on the stock. Citigroup's target price points to a potential upside of 2.46% from the stock's current price.
A number of other brokerages also recently issued reports on VCT. JPMorgan Chase & Co. boosted their price objective on shares of Victrex from GBX 625 to GBX 785 and gave the company a "neutral" rating in a research report on Thursday. Berenberg Bank increased their target price on Victrex from GBX 680 to GBX 870 and gave the company a "hold" rating in a report on Friday. Jefferies Financial Group reaffirmed a "hold" rating and set a GBX 595 price objective on shares of Victrex in a research report on Tuesday, July 7th. Finally, Canaccord Genuity Group cut shares of Victrex to a "buy" rating and set a GBX 725 target price on the stock. in a research note on Friday, May 15th. One equities research analyst has rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, Victrex presently has a consensus rating of "Hold" and a consensus target price of GBX 761.43.
Read Our Latest Stock Analysis on VCT
Victrex Stock Performance
Shares of VCT stock opened at GBX 976 on Friday. The firm's 50 day moving average is GBX 785.53 and its 200 day moving average is GBX 673.74. The company has a current ratio of 2.35, a quick ratio of 1.99 and a debt-to-equity ratio of 21.30. The stock has a market capitalization of £850.64 million, a P/E ratio of -43.57, a PEG ratio of 1.92 and a beta of 0.82. Victrex has a 12 month low of GBX 515 and a 12 month high of GBX 1,024.
Victrex Company Profile
(
Get Free Report)
Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Victrex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Victrex wasn't on the list.
While Victrex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.